Research Article
Insulin Adherence in Type 2 Diabetes in Mexico: Behaviors and Barriers
Table 2
Insulin regimen characteristics according to adherence category.
| Variable | Nonadherent
| Adherent
| |
| Insulin applications/day, number | 2.31 ± 0.96 | 1.76 ± 0.79 | <0.0001 | Insulin dose, units/kg | 0.54 [0.37–0.73] | 0.40 [0.28–0.54] | <0.0001 | Form of insulin application | | | 0.028 | Pen | 21 (17.9) | 26 (31.3) | | Syringe | 96 (82.1) | 57 (68.7) | | Basal insulin | | | 0.046 | NPH | 81 (71.1) | 47 (57.3) | | Basal insulin analogue (glargine U100 and degludec U100) | 33 (28.9) | 35 (42.7) | | Preprandial insulin | | | 0.611 | Regular | 44 (88.0) | 20 (95.2) | | Rapid acting insulin analogue (lispro and aspart) | 6 (12.0) | 1 (4.8) | | Basal-bolus or basal-plus regimen | 50 (42.7) | 21 (25.3) | 0.011 |
|
|
Data are expressed as means ± standard deviation or number (%).
|